Researchers are saying that, from an infection control perspective, C. auris acts more like a multidrug-resistant, healthcare-associated bacteria than like a typical yeast, according to an article on the MedPage website.
"It is a new bug using old tricks mastered by some well-known, multidrug resistant organisms," they said.
Identifying, treating, and preventing Candida auris is a challenge facing more and more healthcare settings.
Findings presented at the 2019 ASM Microbe meeting in San Francisco by researchers from the Centers for Disease Control and Prevention found that patients with C. auris appear to "shed" the pathogen from their skin into their environment, which could potentially play a factor in transmission.
Building Envelope Design: Beyond Energy Efficiency
Outpatient Surge Reshapes Long-Term Strategy for Medical Outpatient Buildings
Mercy Medical Center to Be Integrated into Baystate Health
Managing IAQ in Healthcare Facilities During Wildfires
Building Hospital Resilience in an Era of Extreme Weather